NYSEArca - Delayed Quote USD

iShares Genomics Immunology and Healthcare ETF (IDNA)

24.57 +0.42 (+1.74%)
At close: October 11 at 4:00 PM EDT
24.10 -0.47 (-1.91%)
After hours: October 11 at 4:06 PM EDT
Loading Chart for IDNA
DELL
  • Previous Close 24.15
  • Open 24.20
  • Bid 22.95 x 1200
  • Ask 26.81 x 900
  • Day's Range 24.22 - 24.61
  • 52 Week Range 17.33 - 25.70
  • Volume 23,160
  • Avg. Volume 26,478
  • Net Assets 140.07M
  • NAV 24.57
  • PE Ratio (TTM) 2.40
  • Yield 1.14%
  • YTD Daily Total Return 7.27%
  • Beta (5Y Monthly) 1.13
  • Expense Ratio (net) 0.47%

The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.

iShares

Fund Family

Health

Fund Category

140.07M

Net Assets

2019-06-11

Inception Date

Performance Overview: IDNA

View More

Trailing returns as of 10/11/2024. Category is Health.

YTD Return

IDNA
7.27%
Category
10.57%
 

1-Year Return

IDNA
24.87%
Category
21.36%
 

3-Year Return

IDNA
18.91%
Category
0.43%
 

People Also Watch

Holdings: IDNA

View More

Top 10 Holdings (47.13% of Total Assets)

SymbolCompany% Assets
6160.HK
BeiGene, Ltd. 6.05%
GILD
Gilead Sciences, Inc. 5.13%
EXEL
Exelixis, Inc. 4.70%
ROG.SW
Roche Holding AG 4.70%
BNTX
BioNTech SE 4.69%
SAN.PA
Sanofi 4.62%
RVMD
Revolution Medicines, Inc. 4.45%
INCY
Incyte Corporation 4.43%
4502.T
Takeda Pharmaceutical Company Limited 4.21%
REGN
Regeneron Pharmaceuticals, Inc. 4.15%

Sector Weightings

SectorIDNA
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Related ETF News

View More

Research Reports: IDNA

View More
  • Key Takeaways From Renewable Energy Conference

    Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.

    Rating
    Price Target
     
  • Lowering target price to $109.00

    ENPHASE ENERGY INC has an Investment Rating of HOLD; a target price of $109.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
     
  • Lowering target price to $117.00

    ENPHASE ENERGY INC has an Investment Rating of HOLD; a target price of $117.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
     
  • Lowering target price to $123.00

    ENPHASE ENERGY INC has an Investment Rating of HOLD; a target price of $123.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
     

Related Tickers